Neuropsychological assessment of patients with alzheimer’s Disease in the presence or absence of spouses

2022 ◽  
pp. 1-6
Author(s):  
Mohamad El Haj ◽  
Claire Boutoleau-Bretonnière ◽  
Karim Gallouj ◽  
Philippe Allain ◽  
Pascal Antoine
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Neuropsychological Assessment

P1-312: THE NEUROPSYCHOLOGICAL ASSESSMENT RATING SCALE: A NEW TOOL FOR CHARACTERIZING CLINICAL PHENOTYPES OF ALZHEIMER'S DISEASE

2006 ◽  
Vol 14 (7S_Part_7) ◽  
pp. P411-P411
Author(s):  
Bonnie Wong ◽  
Deepti Putcha ◽  
Scott M. McGinnis ◽  
Megan Quimby ◽  
Brad C. Dickerson
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Neuropsychological Assessment ◽  
Rating Scale ◽  
Clinical Phenotypes

Touch-screen computerized neuropsychological assessment of Alzheimer's disease

2009 ◽  
Vol 5 (5) ◽  
pp. e14-e14
Author(s):  
N. Moore ◽  
P. Fagan ◽  
N. Cooper ◽  
K. Barnett ◽  
E. Miretsky ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Neuropsychological Assessment ◽  
Touch Screen

scholarly journals Overcoming barriers in cognitive assessment of Alzheimer's disease

2014 ◽  
Vol 8 (2) ◽  
pp. 95-98 ◽  
Author(s):  
Mario Alfredo Parra
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Developing Countries ◽  
Neuropsychological Assessment ◽  
Cognitive Assessment ◽  
Developed Countries ◽  
Educational Background ◽  
Assessment Tools ◽  
Cognitive Tests ◽  
The Individual

ABSTRACT Diagnosis of Alzheimer's disease (AD) requires a reliable neuropsychological assessment, but major barriers are still encountered when such tests are used across cultures and during the lifespan. This is particularly problematic in developing countries where most of the available assessment tools have been adapted from developed countries. This represents a major limitation as these tests, although properly translated, may not embody the wealth of challenges that a particular culture poses on cognition. This paper centers on two shortcomings of available cognitive tests for AD, namely, their sensitivity to the educational background and to the age of the individual assessed.

Neuropsychological assessment and cortisol levels in biofluids from early Alzheimer's disease patients

2019 ◽  
Vol 123 ◽  
pp. 10-16 ◽  
Author(s):  
C. Peña-Bautista ◽  
M. Baquero ◽  
I. Ferrer ◽  
D. Hervás ◽  
M. Vento ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Neuropsychological Assessment ◽  
Cortisol Levels ◽  
Early Alzheimer’S Disease
Sign in / Sign up

Export Citation Format

Share Document